Cargando…
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
Matrix metalloproteinases (MMPs) play an essential role in various physiological events. Recent studies have revealed its carcinogenic effect in malignancies. However, the different expression patterns, prognostic value, and immunological value of MMPs in pancreatic ductal adenocarcinoma (PDAC) are...
Autores principales: | Luan, Hong, Jian, Linge, Huang, Yuyan, Guo, Yutong, Zhou, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567842/ https://www.ncbi.nlm.nih.gov/pubmed/37821678 http://dx.doi.org/10.1038/s41598-023-44506-8 |
Ejemplares similares
-
Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
por: Geervliet, Eline, et al.
Publicado: (2020) -
Matrix metalloproteinases as therapeutic targets in breast cancer
por: Kwon, Mi Jeong
Publicado: (2023) -
Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020) -
Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017) -
Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer
por: Zhang, Yangyu, et al.
Publicado: (2020)